XIAOCHUN LU, Ph.D.
*** ******** **., ****** ****, NC 27516
Phone: 269-***-**** (cell); 919-***-**** (home)
Email: **********@*****.***
Professional Overview
• PhD in molecular biology & biochemistry with strong cell culture and cell based assay background.
• Intensive cell culture experience including MSCs, dendritic cells, T cells, primary cells and tumor cell lines with expertise in cell identification using surface marker immunostaining and flow cytometry.
• Experienced in drug discovery industry with extensive knowledge in GLP regulation and SOPs writing.
• 6 years of experience in mechanical engineering department working with different instruments and mechanical systems with strong ability for mechanical system design, setup and operation.
• Experienced in molecular diagnosis development with broad molecular biology and immunology skills.
• High self-motivated, good oral and written communication skills, strong creativity and problem-solving ability, great team player, excellent interpersonal skills, good computer skills.
Professional Experience
SENIOR RESEARCH SPECIALIST
Division of Laboratory Animal Medicine (DLAM), UNC-Chapel Hill April 2010-Jun 2012
Responsibilities: bioassays development & validation under GLP; molecular diagnostic lab setup & management; lead NIH RO1 “Inflammation and Platelet Activation in Cardiovascular Health Disparities”.
SCIENTIST/TRAINED STUDY DIRECTOR
Experimental Therapeutics (ET), MPI Research, Inc. USA July 2008-April 2010
Responsibilities: immunoassay & biochemical assays development under GLP; human disease animal model development & validation; drug efficacy, PD, PK & toxicity study under GLP regulation; project management.
RESEARCH SCIENTIST/POST-DOC
Duke University School of Medicine Jun 2002 – July 2008
Responsibilities: conducted research on novel proteins function in Akt-MSC stem cell therapy for cardio protection; in vitro pulsed immunocytes and dendritic cells mediated immunotherapy for b16 melanoma, transgene expression analysis using real time PCR.
RESEARCH SCIENTIST/PHD FELLOWSHIP
Cardiovascular Research Institute, Peking University Aug 1998 – Jun 2002
Responsibilities: conducted research on gene therapy for EPO-dependent renal anemia and ischemia.
R&D SCIENTIST/ASSOCIATE DIRECTOR
Guilin South Biotechnology, Inc. Nov 1994 – Aug 1998
Responsibilities: conducted drug discovery research on therapetic novel proteins for cardiovascular diseases; biochemical assays and immunoassays development and validation; diagnostic lab management.
SCIENTIST (FERMENTATION & QC)
Guilin Jiqi Pharmaceutical Group, Inc. July 1991-Nov 1994
Responsibilities: fermentation support and QC for antibiotics manufacturing; potency test & strain selection.
Publications (selected)
1. Pallav Bhatnagar, Xiaochun Lu, et al: Genetic variants in Platelet Factor 4 modulate inflammatory and platelet activation biomarkers. Circulation: Cardiovascular Genetics. Accepted on Jun 2012.
2. Xiaochun Lu, Georgy Sankin, et al: Activation of transgene expression in skeletal muscle by focused ultrasound. Biochemical and Biophysical Research Communications, 2009 Feb 6;379(2):428-33.
3. Yifei Xing, Xiaochun Lu, et al: The Effect of High Intensity Focused Ultrasound Treatment on Metastases in a Murine Melanoma Model. Biochemical and Biophysical Research Communications, 2008 Oct 31; 375(4):645-50.
4. Xiaochun. Lu and Pei. Zhong: “Ultrasound-induced cell detachment and gene transfection to adherent cells in vitro”. Acoustic Research Letter Online (ARLO), Vol: 6 (3), 195-200, July 2005.
6. Xiaochun Lu, Airu Zhou and Caike Jin. “The effects of electroporation-mediated erythropoietin (EPO) gene transfer into skeleton muscle on renal anemia”. Chinese Medical Journal (Zhong Hua Yi Xue Za Zhi), Vol.80 (3):222-5, Mar 2000.
7. Xiaochun Lu, et al: “IL-2 and tumor lysate pulsed T cells for tumor adoptive immunotherapy”. ACTA MEDICINAE SINICA (supplemental edition), 1996, Sept (03), 24-28